These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21139258)

  • 1. Evaluation of additives required for periodontal disease formulation using basic fibroblast growth factor.
    Sato Y; Oba T; Natori N; Danjo K
    Chem Pharm Bull (Tokyo); 2010 Dec; 58(12):1582-6. PubMed ID: 21139258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of concomitant use of dental drug on the properties of recombinant human basic fibroblast growth factor formulation for periodontal disease].
    Sato Y; Oba T; Danjo K
    Yakugaku Zasshi; 2013; 133(1):125-31. PubMed ID: 23292029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological Behaviors of Thickened Infant Formula Prepared with Xanthan Gum-Based Food Thickeners for Dysphagic Infants.
    Yoon SN; Yoo B
    Dysphagia; 2017 Jun; 32(3):454-462. PubMed ID: 28271295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases.
    Jones DS; Woolfson AD; Djokic J; Coulter WA
    Pharm Res; 1996 Nov; 13(11):1734-8. PubMed ID: 8956344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of formulation device for periodontal disease.
    Sato Y; Oba T; Watanabe N; Danjo K
    Drug Dev Ind Pharm; 2012 Jan; 38(1):32-9. PubMed ID: 22118220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of IDDSI flow test and line-spread test of thickened water prepared with different dysphagia thickeners.
    Kim YH; Jeong GY; Yoo B
    J Texture Stud; 2018 Dec; 49(6):653-658. PubMed ID: 30187484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow properties of oral contrast medium formulations depend on the temperature.
    Ekberg O; Stading M; Johansson D; Bülow M; Ekman S; Wendin K
    Acta Radiol; 2010 May; 51(4):363-7. PubMed ID: 20380600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical mechanical and tablet formation properties of hydroxypropylcellulose: in pure form and in mixtures.
    Picker-Freyer KM; Dürig T
    AAPS PharmSciTech; 2007 Nov; 8(4):E92. PubMed ID: 18181552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study of wet granulation in fluidized bed: impact of the binder properties on the granule morphology.
    Rajniak P; Mancinelli C; Chern RT; Stepanek F; Farber L; Hill BT
    Int J Pharm; 2007 Apr; 334(1-2):92-102. PubMed ID: 17207948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General properties of silated hydroxyethylcellulose for potential biomedical applications.
    Bourges X; Weiss P; Coudreuse A; Daculsi G; Legeay G
    Biopolymers; 2002 Apr; 63(4):232-8. PubMed ID: 11807750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery.
    Young PM; Traini D; Ong HX; Granieri A; Zhu B; Scalia S; Song J; Spicer PT
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1729-1733. PubMed ID: 28581833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viscosity of dysphagia-oriented cold-thickened beverages: effect of setting time at refrigeration temperature.
    Kim SG; Yoo B
    Int J Lang Commun Disord; 2015; 50(3):397-402. PubMed ID: 25469989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Modified Silicone as a Thickener on Rheology of Liquid CO₂ and Its Fracturing Capacity.
    Li Q; Wang Y; Wang F; Li Q; Kobina F; Bai H; Yuan L
    Polymers (Basel); 2019 Mar; 11(3):. PubMed ID: 30960524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cementum formation in experimentally induced cementum defects of the root surface with the application of recombinant basic fibroblast growth factor in collagen gel in vivo.
    Sato Y; Kikuchi M; Ohata N; Tamura M; Kuboki Y
    J Periodontol; 2004 Feb; 75(2):243-8. PubMed ID: 15068112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptance of different types of thickeners, with and without flavoring, in hospitalized patients with dysphagia - A pilot study.
    Vidal-Casariego A; González-Núñez S; Pita-Gutiérrez F; Lugo-Rodríguez G; Martínez-Ramonde T
    Nutr Hosp; 2021 Oct; 38(5):1082-1088. PubMed ID: 34139853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release.
    Guan J; Stankus JJ; Wagner WR
    J Control Release; 2007 Jul; 120(1-2):70-8. PubMed ID: 17509717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscoelastic interactions between polydeoxyribonucleotide and ophthalmic excipients.
    Kim I; Kim H; Park K; Karki S; Khadka P; Jo K; Kim SY; Ro J; Lee J
    Drug Dev Ind Pharm; 2016; 42(2):231-7. PubMed ID: 26023993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of various excipients on the unfolding of basic fibroblast growth factor.
    Shah D; Johnston TP; Heitz S; Mitra AK
    PDA J Pharm Sci Technol; 1998; 52(5):209-14. PubMed ID: 9846068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease.
    Perioli L; Ambrogi V; Rubini D; Giovagnoli S; Ricci M; Blasi P; Rossi C
    J Control Release; 2004 Mar; 95(3):521-33. PubMed ID: 15023463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.